Total Payments
$1,132
2020 Payments
$54.88
Companies
9
Transactions
55
Medicare Patients
5,523
Medicare Billing
$498,356
Payment Breakdown by Category
Food & Beverage$1,118 (98.8%)
Education$13.89 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,118 | 54 | 98.8% |
| Education | $13.89 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $389.11 | 23 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $199.10 | 8 | $0 (2020) |
| GlaxoSmithKline, LLC. | $162.35 | 8 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $145.32 | 6 | $0 (2019) |
| Medtronic Vascular, Inc. | $91.07 | 1 | $0 (2019) |
| Electromed, Inc. | $58.34 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $51.65 | 3 | $0 (2017) |
| Allergan Inc. | $19.81 | 1 | $0 (2018) |
| Astellas Pharma US Inc | $15.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $54.88 | 2 | Janssen Pharmaceuticals, Inc ($31.57) |
| 2019 | $253.83 | 9 | Medtronic Vascular, Inc. ($91.07) |
| 2018 | $386.07 | 20 | Boehringer Ingelheim Pharmaceuticals, Inc. ($149.53) |
| 2017 | $436.97 | 24 | Boehringer Ingelheim Pharmaceuticals, Inc. ($182.88) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/27/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $31.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/19/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/13/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $28.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/28/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/28/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.53 | General |
| 05/02/2019 | Medtronic Vascular, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $91.07 | General |
| Category: Transcatheter Valve Systems | ||||||
| 03/26/2019 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2019 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.31 | General |
| Category: HFCWO | ||||||
| 01/24/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/06/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/31/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: HFCWO | ||||||
| 07/11/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: ONCOLOGY | ||||||
| 07/10/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: RESPIRATORY | ||||||
| 06/21/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2018 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $12.94 | General |
| Category: HFCWO | ||||||
| 05/29/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: ONCOLOGY | ||||||
| 05/03/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,832 | 2,469 | $698,532 | $172,016 |
| 2022 | 17 | 1,877 | 2,409 | $675,453 | $160,326 |
| 2021 | 15 | 1,169 | 1,394 | $403,986 | $104,474 |
| 2020 | 14 | 645 | 788 | $253,252 | $61,540 |
Total Patients
5,523
Total Services
7,060
Medicare Billing
$498,356
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 363 | 641 | $263,451 | $70,555 | 26.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 114 | 180 | $70,920 | $20,011 | 28.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 232 | 283 | $61,411 | $15,046 | 24.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 76 | 76 | $48,260 | $11,627 | 24.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 66 | $50,886 | $10,526 | 20.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 193 | 242 | $40,172 | $9,978 | 24.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 260 | 369 | $53,136 | $9,310 | 17.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 181 | 200 | $48,200 | $7,251 | 15.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 162 | 186 | $22,320 | $5,410 | 24.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 17 | $14,620 | $4,795 | 32.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 28 | 29 | $5,742 | $2,182 | 38.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 58 | 65 | $8,515 | $1,995 | 23.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 15 | $4,095 | $1,109 | 27.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 30 | $2,100 | $1,079 | 51.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 24 | $1,440 | $863.52 | 60.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 31 | $3,069 | $187.88 | 6.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 12 | 15 | $195.00 | $91.74 | 47.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 324 | 523 | $214,953 | $55,254 | 25.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 122 | 221 | $87,074 | $20,183 | 23.2% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 224 | 269 | $58,373 | $14,407 | 24.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 75 | 76 | $58,596 | $13,446 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 78 | 84 | $46,788 | $13,089 | 28.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 234 | 268 | $44,488 | $10,635 | 23.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 227 | 307 | $44,208 | $7,873 | 17.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 166 | 177 | $42,657 | $6,650 | 15.6% |
About Dr. Farhad Arjomand, MD
Dr. Farhad Arjomand, MD is a Pulmonary Disease healthcare provider based in Eastchester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578679031.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Farhad Arjomand, MD has received a total of $1,132 in payments from pharmaceutical and medical device companies, with $54.88 received in 2020. These payments were reported across 55 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,118).
As a Medicare-enrolled provider, Arjomand has provided services to 5,523 Medicare beneficiaries, totaling 7,060 services with total Medicare billing of $498,356. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Eastchester, NY
- Active Since 08/21/2006
- Last Updated 06/07/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578679031
Products in Payments
- OFEV (Drug) $341.89
- XARELTO (Drug) $199.10
- XOLAIR (Biological) $145.32
- NUCALA (Biological) $134.94
- CoreValve Evolut (Device) $91.07
- SMARTVEST (Device) $58.34
- PNEUMOVAX 23 (Biological) $51.65
- AVYCAZ (Drug) $19.81
- ANORO (Drug) $16.44
- CRESEMBA (Drug) $15.00
- STIOLTO (Drug) $13.89
- PRADAXA (Drug) $13.80
- BREO (Drug) $10.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Eastchester
Dr. Michael Morelli, Md, MD
Pulmonary Disease — Payments: $361.56
Pulmonary Disease $361.56
Thaofiq Ijaiya
Pulmonary Disease — Payments: $271.42
Pulmonary Disease $271.42
Dr. Ralph Binder, Md, MD
Pulmonary Disease — Payments: $23.11
Pulmonary Disease $23.11
Dr. Miroslav Nudelman, Md, MD
Pulmonary Disease
Pulmonary Disease